Shares of Progenics Pharmaceuticals (NASDAQ: PGNX) are surging 26% mid-day after the company and partner Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE